Comparing two ways to give the R21 malaria vaccine in Chad
Part of Infections clinical trials.
This study tests two ways of giving the R21 malaria vaccine to children in Chad during the rainy season. One way follows the routine vaccination schedule, and the other gives the vaccine at the same time as seasonal malaria prevention medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 months and 5 years old, depending on the vaccine schedule.
- Your child must live in a village that is part of the study.
- You must give permission for your child to take part (oral consent).
- Your child should not have had a severe allergic reaction to a malaria vaccine, hepatitis B vaccine, or any part of the R21 vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
This study tests a new malaria vaccine (called R21/MM) given in different doses and forms. If you qualify, you'll help find a better way to protect against malaria.
This trial tests if adding a malaria vaccine to seasonal preventive medicines helps protect young children better from malaria. It is for healthy children living in certain areas of Burkina Faso and Mali.
This study looks at how well the R21/Matrix-M malaria vaccine works and how safe it is in children who received it. It compares children who got malaria (or died) to healthy children who also got the vaccine.
This study looks at how well the R21/Matrix-M malaria vaccine works in real-life settings for children under 5. If your child is eligible for the vaccine and has a fever, they may be able to join and help us understand the vaccine's impact.
This study tests two different malaria vaccines to see which is safer and works better. Participants will receive one of the vaccines and then be exposed to a safe form of the malaria parasite to check if it protects them.
Hear when a new Malaria Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.